US2018207136A1PendingUtilityA1
Ophthalmic pharmaceutical compositions and uses relating thereto
Assignee: ORASIS PHARMACEUTICALS LTDPriority: Aug 19, 2016Filed: Nov 29, 2017Published: Jul 26, 2018
Est. expiryAug 19, 2036(~10.1 yrs left)· nominal 20-yr term from priority
A61P 43/00A61P 27/02A61P 27/10A61P 27/00A61K 31/133A61K 47/36A61K 47/38A61K 31/365A61K 9/0048A61K 31/4178A61K 31/728A61K 31/196A61K 31/407A61K 2300/00A61K 9/0051
60
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The disclosure relates to ophthalmic pharmaceutical compositions comprising pilocarpine or a pharmaceutically acceptable salt. Aspects of the disclosure further relate to uses and preparations of ophthalmic pharmaceutical compositions comprising pilocarpine or a pharmaceutically acceptable salt, for correcting presbyopia and other ocular conditions in a subject.
Claims
exact text as granted — not AI-modified1 . An ophthalmic pharmaceutical composition comprising pilocarpine or a pharmaceutically acceptable salt thereof at a concentration of 0.01% (w/w or w/v) to 0.4% (w/w or w/v) and a pharmaceutically acceptable carrier.
2 .- 70 . (canceled)Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.